We thus tested the effects of combined LXH254 and trametinib in four xenograft models of NF1-MPNST, including three patient-derived (JH-2–002, JH-2-079c and MA1334) and one cell-line derived (ST8814). This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.